Nuclear power is getting a second life, but not in the form most people imagine. Instead of massive concrete giants, the future may come from compact reactors built in factories and shipped like industrial equipment. As global energy demand surges and grids strain under new pressures, small modular reactors are suddenly at the centre of the conversation.
Cosmo Pharmaceuticals’ successful Phase III trials in male hair loss has drawn attention to a market long seen as cosmetic. Growing demand for effective treatments has accelerated research and encouraged the rise of biotechnology companies exploring new approaches.
Meanwhile, bitcoin and software equities are moving like twins. Each week, the Syz investment team takes you through the last seven days in seven charts.
Slow food for thought
Insights and research on global events shaping the markets
Nuclear power is getting a second life, but not in the form most people imagine. Instead of massive concrete giants, the future may come from compact reactors built in factories and shipped like industrial equipment. As global energy demand surges and grids strain under new pressures, small modular reactors are suddenly at the centre of the conversation.
Cosmo Pharmaceuticals’ successful Phase III trials in male hair loss has drawn attention to a market long seen as cosmetic. Growing demand for effective treatments has accelerated research and encouraged the rise of biotechnology companies exploring new approaches.
Straight from the Desk
Syz the moment
Live feeds, charts, breaking stories, all day long.
Fast food for thought
Insights and research on global events shaping the markets
US rates edged lower amid labor market concerns while credit markets were impacted by equity market volatility
Meanwhile, bitcoin and software equities are moving like twins. Each week, the Syz investment team takes you through the last seven days in seven charts.
Crypto corner
A monthly deep dive into crypto assets
AI Insights
Hand-curated selection of the latest developments in the AI world
Investing with intelligence
Our latest research, commentary and market outlooks